Successful Treatment of Acromegaly and Associated Hypogonadism with First-Line Clomiphene Therapy
Clomiphene citrate (CC) has been reported as an effective add-on therapy to somatostatin analogs and dopamine agonists in patients with acromegaly accompanied by hypogonadism; its use as a single agent to treat acromegaly and associated hypogonadism following incomplete surgery has not been previous...
Saved in:
Main Authors: | Juan D. Palacios, Ricardo J. Komotar, Atil Y. Kargi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Case Reports in Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2018/7925019 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Connecting the Lines between Hypogonadism and Atherosclerosis
by: Akl C. Fahed, et al.
Published: (2012-01-01) -
Association of Beta-Thalassaemia and Hypogonadotropic Hypogonadism
by: Angela Vidal, et al.
Published: (2022-01-01) -
Success Rates of Clomiphene Citrate and Recombinant Gonadotropin Cycles: A Single-Center Experience
by: Beril Gurlek, et al.
Published: (2020-03-01) -
Hypogonadotropic Hypogonadism Associated with Hereditary Hemorrhagic Telengiectasia
by: Scarano Valentina, et al.
Published: (2013-01-01) -
Clomiphene Citrate versus Clomiphene Citrate in combination with other drugs in Ovulation Induction in Patients with Polycystic Ovary Syndrome
by: Mostafa Khodary, et al.
Published: (2025-07-01)